JO2334B1 - Drospirenone for hormone replacement therapy - Google Patents
Drospirenone for hormone replacement therapyInfo
- Publication number
- JO2334B1 JO2334B1 JO200110A JOP20010010A JO2334B1 JO 2334 B1 JO2334 B1 JO 2334B1 JO 200110 A JO200110 A JO 200110A JO P20010010 A JOP20010010 A JO P20010010A JO 2334 B1 JO2334 B1 JO 2334B1
- Authority
- JO
- Jordan
- Prior art keywords
- estrogen
- beta
- menopausal
- drospirenone
- hormone replacement
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200183 | 2000-01-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO2334B1 true JO2334B1 (en) | 2006-06-28 |
Family
ID=38170612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JO200110A JO2334B1 (en) | 2000-01-18 | 2001-01-11 | Drospirenone for hormone replacement therapy |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR035633A1 (es) |
CO (1) | CO5280075A1 (es) |
HR (1) | HRP20070360B1 (es) |
JO (1) | JO2334B1 (es) |
PE (1) | PE20011051A1 (es) |
SA (1) | SA01210754B1 (es) |
UA (2) | UA81388C2 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4426601A1 (de) * | 1994-07-27 | 1996-02-01 | Schering Ag | Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri |
DE19654609A1 (de) * | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder |
IL148339A0 (en) * | 1999-08-31 | 2002-09-12 | Schering Ag | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
-
2001
- 2001-01-11 JO JO200110A patent/JO2334B1/en active
- 2001-01-15 PE PE2001000035A patent/PE20011051A1/es active IP Right Grant
- 2001-01-17 AR ARP010100199 patent/AR035633A1/es not_active Application Discontinuation
- 2001-01-17 CO CO01003045A patent/CO5280075A1/es not_active Application Discontinuation
- 2001-01-18 UA UA2002086809A patent/UA81388C2/uk unknown
- 2001-01-18 UA UAA200612100A patent/UA89180C2/ru unknown
- 2001-03-21 SA SA01210754A patent/SA01210754B1/ar unknown
-
2007
- 2007-08-17 HR HRP20070360AA patent/HRP20070360B1/hr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HRP20070360A2 (en) | 2008-12-31 |
CO5280075A1 (es) | 2003-05-30 |
PE20011051A1 (es) | 2001-10-17 |
SA01210754B1 (ar) | 2007-02-17 |
UA89180C2 (ru) | 2010-01-11 |
UA81388C2 (en) | 2008-01-10 |
HRP20070360B1 (hr) | 2014-11-21 |
AR035633A1 (es) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU54602A (sh) | Drospirenon za terapiju zamene hormona | |
MADANES et al. | Danazol | |
NZ516502A (en) | Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG) | |
CA2205897A1 (en) | Compositions and methods for contraception and for treatment of benign gynecological disorders | |
KR20090080989A (ko) | 여성 리비도의 유지 및/또는 증가를 위한 경구 치료요법을 위한 디에노게스트와 조합된 에스트라디올 발레레이트 또는 17β-에스트라디올의 용도 | |
EP0799042A1 (de) | Progesteronantagonistisch- und antiöstrogen wirksame verbindungen zur gemeinsamen verwendung für die weibliche kontrazeption | |
US20110009373A1 (en) | Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis | |
Thorneycroft | Update on androgenicity | |
TR199900764T2 (xx) | Bir �strojen bile�i�i ve progestasyonel bir bile�ikten olu�an hormonal bir terkip. | |
JO2334B1 (en) | Drospirenone for hormone replacement therapy | |
Shulman | A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone | |
CA2248841C (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
Whitehead | Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data | |
HRP20020666A8 (en) | Drospirenone for hormone replacement therapy | |
Schindler | Antriandrogen therapy for signs of androgenization: an overview | |
Schindler | COMPOUND CEMICAL STRUCTURE Cimetidine Flutamide | |
TH134365B (th) | โดรสไพริโนนสำหรับการรักษาด้วยการแทนที่ฮอร์โมน | |
MXPA98007513A (es) | Combinacion secuencial de estrogeno/antagonista de progesterona para terapia de reemplazo de hormonas | |
MXPA01008772A (es) | Uso de hormonas sexuales para obtener una composicion farmaceutica nasal que es util en el tratamiento del sangrado uterino indeseable | |
TH134365A (th) | โดรสไพริโนนสำหรับการรักษาด้วยการแทนที่ฮอร์โมน |